A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents

César Soutullo, Tobias Banaschewski, Michel Lecendreux, Mats Johnson, Alessandro Zuddas, Colleen Anderson, Richard Civil, Nicholas Higgins, Ralph Bloomfield, Liza A. Squires, David R. Coghill

    Research output: Contribution to journalArticlepeer-review

    32 Citations (Scopus)

    Abstract

    There are limited head-to-head data comparing the efficacy of long-acting amfetamine- and methylphenidate-based psychostimulants as treatments for individuals with attention-deficit hyperactivity disorder (ADHD). This post hoc analysis provides the first parallel-group comparison of the effect of lisdexamfetamine dimesylate (lisdexamfetamine) and osmotic-release oral system methylphenidate (OROS-MPH) on symptoms of ADHD in children and adolescents.
    Original languageEnglish
    JournalCNS Drugs
    DOIs
    Publication statusPublished - 26 Jun 2013

    Fingerprint Dive into the research topics of 'A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents'. Together they form a unique fingerprint.

    Cite this